[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [9k=] --------------------------------------------------------------- [The Man, Whose Crypto Trades Have Soared 1,061% ... 1,934% ... and 18,235% - All in Less Than a Year, Reveals His Next Crypto Trade]( [Details here.]([aff_i?offer_...] --------------------------------------------------------------- September 9, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Palatin Technologies, PTN]( Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Palatin Technologies (PTN)](in the Healthcare sector with a Buy rating and a price target of $70.00 (1 day ago). - Recent Price: $6.6 - Average Analyst Price Target: $60.00 (809.09%) - Market Cap: $58.50M [TipRanks.com]( also reports that [Palatin Technologies](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $60.00. The target pricing ranges from a high forecast of $70.00 down to a low forecast of $50.00. [Palatin Technologies (PTN)](’s last closing price was $6.6 which would put the average price target at $60.00. Here are 3rd party ratings for [PTN](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 28% (71 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Is Apple Pointing to a Massive Recession in the U.S.?]( Apple (AAPL) is making moves behind the scenes to prepare for a downturn… Bloomberg recently reported that the tech giant plans to freeze hiring in some divisions- while remaining cautious on spending through next year. And the thing is, Apple isn’t alone…[Bottom-line: Apple might be pointing to a massive recession in the U.S.]( If you have any serious assets in the market, there is [one critical step you must take now.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Asana, ASAN]( Recent Analyst Action: Alex Zukin, analyst at Wolfe Research, reiterates coverage on [Asana (ASAN)](in the Technology sector with a Buy rating and a price target of $23.75 (1 day ago). - Recent Price: $24.05 - Average Analyst Price Target: $30.09 (25.11%) - Market Cap: $4.52B [TipRanks.com]( also reports that [Asana](currently has 8 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $30.09. The target pricing ranges from a high forecast of $65.00 down to a low forecast of $15.00. [Asana (ASAN)](’s last closing price was $24.05 which would put the average price target at $30.09. Here are 3rd party ratings for [ASAN](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 44% (140 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Dice Therapeutics, DICE]( Recent Analyst Action: Alex Thompson, analyst at Stifel Nicolaus, reiterates coverage on [Dice Therapeutics (DICE)](in the Healthcare sector with a Buy rating and a price target of $37.00 (3 days ago). - Recent Price: $22.09 - Average Analyst Price Target: $41.00 (85.60%) - Market Cap: $844.08M [TipRanks.com]( also reports that [Dice Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $41.00. The target pricing ranges from a high forecast of $46.00 down to a low forecast of $37.00. [Dice Therapeutics (DICE)](’s last closing price was $22.09 which would put the average price target at $41.00. Here are 3rd party ratings for [DICE](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 28% (71 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Exclusive: "I'm Investing $100K in This" - Daymond John]( I launched my startup in my mother’s basement with $40 and grew it into a $6 billion fashion empire. I couldn’t have done it without my first angel investor. It’s time to pay it forward. So I’m launching a special mission to discover our nation’s greatest visionaries before the world knows them by one name like “Musk, Jobs, and Gates.” [And I’m recruiting you to join me.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Augmedix, AUGX]( Recent Analyst Action: Marc Wiesenberger, analyst at B.Riley Financial, reiterates coverage on [Augmedix (AUGX)](in the Services sector with a Buy rating and a price target of $4.5 (1 month ago). - Recent Price: $2.08 - Average Analyst Price Target: $4.25 (104.33%) - Market Cap: $77.46M [TipRanks.com]( also reports that [Augmedix](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.25. The target pricing ranges from a high forecast of $4.50 down to a low forecast of $4.00. [Augmedix (AUGX)](’s last closing price was $2.08 which would put the average price target at $4.25. Here are 3rd party ratings for [AUGX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 39% (97 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Nordic American Tanker, NAT]( Recent Analyst Action: Omar Nokta, analyst at Jefferies, reiterates coverage on [Nordic American Tanker (NAT)](in the Industrial Goods sector with a Buy rating and a price target of $4.00 (3 days ago). - Recent Price: $3.175 - Average Analyst Price Target: $3.08 (-2.99%) - Market Cap: $619.14M [TipRanks.com]( also reports that [Nordic American Tanker](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.08. The target pricing ranges from a high forecast of $4.00 down to a low forecast of $2.40. [Nordic American Tanker (NAT)](’s last closing price was $3.175 which would put the average price target at $3.08. Here are 3rd party ratings for [NAT](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 20% (49 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Will This Be the Worst U.S. Crisis Ever?]( [b9dbbf1c-e7c...](Wealthy 73-year-old U.S. entrepreneur retreats to one of his three European properties to issue serious warning (and 4 recommendations) for Americans. "It falls on someone like me to warn you clearly. I'm too rich to care about money—and too old to care what anyone thinks." [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Wingstop, WING]( Recent Analyst Action: David Tarantino, analyst at Robert W. Baird, reiterates coverage on [Wingstop (WING)](in the Services sector with a Buy rating (3 weeks ago). - Recent Price: $146.06 - Average Analyst Price Target: $127.42 (-12.76%) - Market Cap: $4.35B [TipRanks.com]( also reports that [Wingstop](currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $127.42. The target pricing ranges from a high forecast of $150.00 down to a low forecast of $70.00. [Wingstop (WING)](’s last closing price was $146.06 which would put the average price target at $127.42. Here are 3rd party ratings for [WING](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 27% (182 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Finch Therapeutics Group, FNCH]( Recent Analyst Action: Vernon Bernardino, analyst at H.C. Wainwright, reiterates coverage on [Finch Therapeutics Group (FNCH)](in the Healthcare sector with a Buy rating and a price target of $17.00 (3 weeks ago). - Recent Price: $2.65 - Average Analyst Price Target: $17.00 (541.51%) - Market Cap: $125.42M [TipRanks.com]( also reports that [Finch Therapeutics Group](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $17.00. The target pricing ranges from a high forecast of $17.00 down to a low forecast of $17.00. [Finch Therapeutics Group (FNCH)](’s last closing price was $2.65 which would put the average price target at $17.00. Here are 3rd party ratings for [FNCH](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 32% (80 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Dividends Paid Every Week- Regular as Clockwork]( [8b1be9c8-835...](I've been studying two new stocks carefully and they've both been paying dividends every week — regular as clockwork. One’s more aggressive and pays a nickel per share every Friday. The second is expected to yield 3% - 4% in the first year. And it also pays every Thursday. We can use these two new ETFs to pay for our groceries, gas or restaurant bills. Or, reinvest the dividends and quickly snowball our nest eggs to help meet our retirement goals. Today, I want to share this information with you, absolutely free. [Click here for details.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketMoversInsider.com Disclaimer This email/newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this email/newsletter is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this email/newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our email/newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketMoversInsider.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville | NC | 28115 MarketMoversInsider.com | 165 Lockerbie Lane | Moorsville | North Carolina | 28115 | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software